Linzess and Gastric Emptying Scans
Linzess (linaclotide) should be discontinued prior to a gastric emptying scintigraphic scan, as it accelerates gastrointestinal transit specifically in the colon, which could theoretically interfere with accurate assessment of gastric emptying if there are downstream effects on overall GI motility.
Mechanism and Transit Effects
Linaclotide is a guanylate cyclase-C agonist that increases intestinal fluid secretion and accelerates GI transit 1. However, its effects are anatomically specific:
- Colonic effects predominate: Linaclotide significantly accelerates colonic transit time (median reduction from 2650 to 1757 minutes) and increases colonic motility index 2
- No gastric effects demonstrated: Research shows linaclotide has no effect on gastric emptying or small bowel transit 2
- Mechanism is localized: The drug increases luminal chloride and bicarbonate secretion, thereby increasing intestinal fluid and accelerating GI transit primarily in the colon 1
Clinical Reasoning for Discontinuation
While the evidence shows linaclotide does not directly affect gastric emptying 2, there are practical reasons to hold the medication:
- Diarrhea as confounding factor: 16-20% of patients experience diarrhea on linaclotide 3, which could complicate scan interpretation and patient comfort during the 4-hour test
- Altered bowel patterns: The medication increases spontaneous bowel movement frequency by approximately 2 movements per week 1, potentially causing urgency during the scan
- Standard practice for motility testing: Most GI motility protocols recommend holding medications that affect GI transit to obtain baseline measurements
Practical Recommendations
Timing of discontinuation:
- Hold linaclotide for at least 48-72 hours before the gastric emptying scan
- The majority of diarrhea cases occur within the first 2 weeks of treatment, but effects on colonic transit persist during therapy 3, 2
- Systemic absorption is minimal, so washout period is primarily to allow return of baseline colonic function 1
Common pitfalls to avoid:
- Do not assume the medication needs to be held for weeks—2-3 days is sufficient given its mechanism of action 1
- Ensure other medications affecting GI motility (prokinetics, anticholinergics, opioids) are also addressed
- Document the hold period clearly, as patients may need to resume therapy promptly after the scan